A Study to Assess the Safety, Tolerability, and Pharmacokinetics of Cefiderocol in Hospitalized Neonates and Infants

Clinical trial NCT06086626 · COMPLETED

Trial details

NCT number: NCT06086626
Sponsor: Shionogi
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Gram-Negative Bacterial Infections

Start date: 2024-03-14
Primary completion: 2025-03-31
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.